View on web

THE TOP NEWS IN MARIJUANA LAW REFORM

Volume 26   •   Issue 47   •   November 30, 2023

Investigators concluded, “Medical cannabis may have minimal acute impact on cognitive function when prescribed and used as directed.”

More than 80 percent of respondents said that they had eliminated their use of over the counter and prescription sleep aids after switching to cannabis.

Survey: More Than Ten Percent of Older Americans Have Consumed Cannabis Products in the Past Year  11/27/23

Study: Cannabis Use Associated With Improved Symptoms, Better Sleep in Patients Suffering From Post-Traumatic Stress  11/21/23

NORML Op-Ed: Republicans Are Increasingly Unwilling to Respect Voters’ Decisions on Cannabis  11/20/23

Government Survey: Teen Marijuana Use Remains Below Pre-Pandemic Levels  11/17/23

"This [finding] seems to suggest that this therapy should be considered in addition to current therapies for cancer-related pain.”

FEDERAL: Let VA Doctors Recommend Medical Cannabis in Military Spending Bill

FEDERAL: Tell Your Senators to Support the SAFER Banking Act

FEDERAL: Tell Your Representatives to Support the CURE Act

FEDERAL: Support Medical Cannabis Research and Access for Veterans

FEDERAL: Tell Congress to Prioritize Cannabis Policy Reform in 2023

FEDERAL: Support the Veterans Equal Access Act

Maine law does not mandate third-party lab testing for medical cannabis products.

There are now a total of six licensed producers in the state.

FEDERAL: Loosening restrictions on marijuana may not be boon for reform

LEARN: Data supports reforming marijuana drug testing laws for federally-licensed employees

INDIANA: Legislators, advocates continue to push for marijuana reform at the statehouse in 2024

OHIO: Legalization faces tough odds in red states despite Ohio victory

NORML's mission is supported by thousands of people across America as we work to reform marijuana laws in all 50 states and at the federal level.

Can you chip in $5 today to help us keep up the fight?